Asia Pacific Non-Invasive Cancer Diagnostics market size was approximately USD 20.9 billion in 2018 and showing a huge increase with a CAGR of 7.9% and is anticipated to reach USD 31.4 billion by 2023.
Non-Invasive Cancer is a multicentre one, in which the tumours formed will spread out the entire place where they are formed. DCIS is a Non-Invasive Cancer generally found in milk ducts and this is a type of breast cancer.
The hike in this market is driven by several factors some of them include an increase in the number of people who are diagnosed with cancer every year, smoking tobacco, exposing the body to different types of radiations, heredity, chemicals. Introducing new ways of treating cancers also increasing the market share. The high cost of treatment may drag back the market value in some of the developing countries.
The market is segmented by technology and by therapeutics. By technology, the market is categorized into molecular diagnostics, clinical chemistry, clinical instruments, and immunochemistry. With the advancement in technology, the market of molecular diagnostics is increasing at an exponential rate. By therapeutics, the market is further divided into solid tumours, breast cancer, blood cancer, lung cancer, and other cancers. According to recent studies every year, more than 15 million new cancer cases are diagnosed and most of them are found to be breast cancers and lung cancers. Breast cancer accounted for the major market share in the recent years. Many non-profit organizations came into the picture to help people and increased awareness about symptoms and treatment process of the breast cancer which is helping the market to increase its size. Lung cancer is one of the major types of cancer diagnosed in huge number and the number is increasing every year.
By geography, the market is segmented into India, China, Japan, South Korea, and others. In developing countries like India and China, the market is showing a considerable rise in the past few years and looking forward to increase furthermore with the increased funding for cancer research.
Companies providing the best treatment for cancer in the market include Gen Probe Inc., Abbott Laboratories, Quest Diagnostics Inc., Cancer Genetics Inc., Hologic Inc., Myriad Genetics Inc., Bioview Inc., Volcano Corp., Laboratory Corporation of America Holdings, Precision Therapeutics. Digene Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Molecular Diagnostics
5.1.3 Clinical Chemistry
5.1.4 Clinical Instruments
5.1.5 Immunochemistry
5.1.6 Y-o-Y Growth Analysis, By Technology
5.1.7 Market Attractiveness Analysis, By Technology
5.1.8 Market Share Analysis, By Technology
5.2 Therapeutics
5.2.1 Introduction
5.2.2 Solid Tumours
5.2.3 Blood Cancer
5.2.4 Lung Cancer
5.2.5 Breast Cancer
5.2.6 Y-o-Y Growth Analysis, By Therapeutics
5.2.7 Market Attractiveness Analysis, By Therapeutics
5.2.8 Market Share Analysis, By Therapeutics
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Therapeutics
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Thechnology
6.1.4.3 By Therapeutics
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Therapeutics
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Gen Probe Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abbott Laboratories
8.3 Quest Diagnostics
8.4 Cancer Genetics
8.5 Hologic Inc
8.6 Myraid Genetics
8.7 Bioview Inc
8.8 Volcano Corp
8.9 Laboratory Corporation Of America Holdings
8.10 Precision Therapeutics
8.11 Digene Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
